Small cell lung cancer (SCLC) is a highly aggressive and lethal neuroendocrine lung cancer characterized by transcriptional deregulation, with mutations in the well-known transcriptional regulators p53 and retinoblastoma (Rb) being critical for its development [2]. Here, TP53 is linked to small cell lung carcinoma.